The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $111.16

Today's change+1.69 +1.54%
Updated June 28 12:11 PM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $111.16

Today's change+1.69 +1.54%
Updated June 28 12:11 PM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc Hits New 100-day High

Quest Diagnostics Inc is up sharply today, rallying (U.S.)$1.69 or 1.54% to (U.S.)$111.16 and setting a new 100-day high. Over the last five days, shares have gained 1.95% and 20.95% year to date. Shares have outperformed the S&P 500 by 22.28% during the last year.

Key company metrics

  • Open(U.S.) $110.19
  • Previous close(U.S.) $109.47
  • High(U.S.) $111.43
  • Low(U.S.) $109.85
  • Bid / Ask(U.S.) $111.14 / (U.S.) $111.17
  • YTD % change+20.95%
  • Volume312,491
  • Average volume (10-day)888,764
  • Average volume (1-month)812,071
  • Average volume (3-month)862,909
  • 52-week range(U.S.) $77.50 to (U.S.) $111.43
  • Beta0.70
  • Trailing P/E22.25×
  • P/E 1 year forward19.66×
  • Forward PEG2.41×
  • Indicated annual dividend(U.S.) $1.80
  • Dividend yield1.62%
  • Trailing EPS(U.S.) $5.00
Updated June 28 12:11 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.37%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue1,8991,8611,8851,906
Total other revenue--------
Total revenue1,8991,8611,8851,906
Gross profit736760729753
Total cost of revenue1,1631,1011,1561,153
Total operating expense1,6201,5851,5631,484
Selling / general / administrative436363407429
Research & development--------
Depreciation / amortization17181817
Interest expense (income), net operating--------
Unusual expense (income)3963-115
Other operating expenses, total17-210
Operating income279276322422
Interest income (expense), net non-operating-37-36-37-35
Gain (loss) on sale of assets--------
Other--------
Income before tax253251300392
Income after tax175167205209
Income tax, total788495183
Net income164155192195
Total adjustments to net income--0-2-1
Net income before extra. items164155192195
Minority interest-11-12-13-14
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items164155190194
Inc. avail. to common incl. extra. items164155190194
Diluted net income164155192194
Dilution adjustment----2--
Diluted weighted average shares141139142142
Diluted EPS excluding extraordinary itemsvalue per share1.161.121.351.37
Dividends per sharevalue per share0.450.400.400.40
Diluted normalized EPSvalue per share1.181.571.370.93